231 related articles for article (PubMed ID: 16548245)
1. [Monoclonal gammopathies of undetermined significance].
Ifrah N; Zandecki M
Rev Prat; 2006 Jan; 56(1):18-24. PubMed ID: 16548245
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal gammopathy of undetermined significance.
Kyle RA; Rajkumar SV
Clin Lymphoma Myeloma; 2005 Sep; 6(2):102-14. PubMed ID: 16231848
[TBL] [Abstract][Full Text] [Related]
3. [Monoclonal gammopathies in a series of 1683 plasma donors].
Tichý M; Rehácek V; Maisnar V; Dominiková K; Palicka V
Cas Lek Cesk; 2004; 143(6):401-4; discussion 404. PubMed ID: 15309868
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
Kyle RA; Rajkumar SV
Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088
[TBL] [Abstract][Full Text] [Related]
5. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.
International Myeloma Working Group
Br J Haematol; 2003 Jun; 121(5):749-57. PubMed ID: 12780789
[TBL] [Abstract][Full Text] [Related]
6. [Monoclonal gammopathies of undetermined significance].
Krizalkovicová V; Maisnar V; Pour L; Radocha J; Hájek R
Klin Onkol; 2008; 21(4):160-4. PubMed ID: 19102222
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal gammopathy of undetermined significance (MGUS) in patients with solid tumors: effects of chemotherapy on the monoclonal protein.
Anagnostopoulos A; Galani E; Gika D; Sotou D; Evangelopoulou A; Dimopoulos MA
Ann Hematol; 2004 Oct; 83(10):658-60. PubMed ID: 15278296
[TBL] [Abstract][Full Text] [Related]
8. [Nosology and management of monoclonal gammapathy].
Grosbois B; Decaux O; Guenet L; Goasguen J; Jego P
Bull Acad Natl Med; 2009 May; 193(5):1069-85; discussion 1085-7. PubMed ID: 20120388
[TBL] [Abstract][Full Text] [Related]
9. Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance?
Elis A; Radnay J; Shapiro H; Itzhaky D; Manor Y; Lishner M
Isr Med Assoc J; 2006 Dec; 8(12):840-2. PubMed ID: 17214099
[TBL] [Abstract][Full Text] [Related]
10. [Incidence, clinico-biological characteristics, and clinical course of 1,203 monoclonal gammopathies (1971-1992)].
Giraldo P; Rubio-Félix D; Cortés T; Delgado P; Franco E; Gimeno J; Tapia M; Giralt M
Sangre (Barc); 1994 Oct; 39(5):343-50. PubMed ID: 7754438
[TBL] [Abstract][Full Text] [Related]
11. [Acquired peripheral neuropathies associated with monoclonal gammopathy].
Gajos A; Kieliś W; Szadkowska I; Chmielowska E; Niewodniczy A; Bogucki A
Neurol Neurochir Pol; 2007; 41(2):169-75. PubMed ID: 17530580
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal gammopathies and malignancies in patients with chronic urticaria.
Karakelides M; Monson KL; Volcheck GW; Weiler CR
Int J Dermatol; 2006 Sep; 45(9):1032-8. PubMed ID: 16961504
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal gammopathies of undetermined significance.
Kyle RA; Rajkumar SV
Best Pract Res Clin Haematol; 2005; 18(4):689-707. PubMed ID: 16026745
[TBL] [Abstract][Full Text] [Related]
14. Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?
Gobbi PG; Baldini L; Broglia C; Goldaniga M; Comelli M; Morel P; Morra E; Cortelazzo S; Bettini R; Merlini G
Clin Cancer Res; 2005 Mar; 11(5):1786-90. PubMed ID: 15756000
[TBL] [Abstract][Full Text] [Related]
15. Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance.
Rossi F; Petrucci MT; Guffanti A; Marcheselli L; Rossi D; Callea V; Vincenzo F; De Muro M; Baraldi A; Villani O; Musto P; Bacigalupo A; Gaidano G; Avvisati G; Goldaniga M; Depaoli L; Baldini L
Clin Cancer Res; 2009 Jul; 15(13):4439-45. PubMed ID: 19509142
[TBL] [Abstract][Full Text] [Related]
16. [Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital].
Uchida M; Taida N; Kanao M; Kagamihara H; Kuwajima M
Rinsho Byori; 2004 Jul; 52(7):574-9. PubMed ID: 15344556
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of monoclonal gammopathy of undetermined significance.
Kyle RA; Therneau TM; Rajkumar SV; Larson DR; Plevak MF; Offord JR; Dispenzieri A; Katzmann JA; Melton LJ
N Engl J Med; 2006 Mar; 354(13):1362-9. PubMed ID: 16571879
[TBL] [Abstract][Full Text] [Related]
18. Peripheral neuropathies associated with monoclonal gammopathies of undetermined significance.
Kelly JJ
Rev Neurol Dis; 2008; 5(1):14-22. PubMed ID: 18418318
[TBL] [Abstract][Full Text] [Related]
19. [Monoclonal gammopathies of undetermined significance and their progression over time. Retrospective study of 190 patients].
Decaux O; Cuggia M; Ruelland A; Cazalets C; Cador B; Jego P; Grosbois B
Presse Med; 2006; 35(7-8):1143-50. PubMed ID: 16840890
[TBL] [Abstract][Full Text] [Related]
20. Biclonal gammopathy in multiple myeloma: a case report.
Bakta IM; Sutarka IN
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():544-8. PubMed ID: 10895208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
